To D or not to D – an in vitro/mass spectrometry screening method to confirm improved metabolic stability in deuterium-labelled radiotracers

dc.contributor.authorMurphy, RBen_AU
dc.contributor.authorWyatt, NAen_AU
dc.contributor.authorFraser, BHen_AU
dc.contributor.authorYepuri, NRen_AU
dc.contributor.authorHolden, PJen_AU
dc.contributor.authorWotherspoon, ATLen_AU
dc.contributor.authorDarwish, TAen_AU
dc.date.accessioned2021-09-22T01:48:11Zen_AU
dc.date.available2021-09-22T01:48:11Zen_AU
dc.date.issued2019-09-03en_AU
dc.date.statistics2021-09-20en_AU
dc.description.abstractDeuteration, where hydrogen within molecules is switched with the non-radioactive and naturally occurring isotope deuterium, can lead to enhanced material properties. For example, the deuterium kinetic isotope effect is well known to improve the metabolic stability of molecules such as drugs, as the C–D bond is stronger and more difficult for enzymes to break than the C–H bond. However, the specific molecular location to deuterate to gain a metabolically favourable outcome may not be clear, without undertaking separate assays of both the deuterated and non-deuterated molecules, followed by separate HPLC-UV/radiometric measurement. In the case of compounds which also contain a radiolabel (e.g. radiotracers for diagnostic medical imaging), specialist infrastructure and teams are required, and chemical synthesis and bioanalysis are time-critical. Our ongoing work with the radiotracer [18F]PBR111, a TSPO ligand showing potential for imaging neuroinflammation1,2,3, demonstrated that [18F]PBR111-d4 (where d4 is incorporated at a specific site) has slower metabolic breakdown4,5 and a decreased rate of formation of polar metabolites in vitro (rat and human liver microsomes) relative to non-deuterated 5,6. Our recently published MS/MS method4 demonstrates the relative difference in metabolic stability without radiolabelling, by analysing different time points from a liver microsome assay which has been administered a 50:50 mixture of deuterated/non-deuterated compound. Pharmacokinetic parameters can also be determined from the data. Deuteration adjacent to the fluoro-alkyl group in PBR111 showed ~50% improvement in the stability of the intact radiotracer relative to non-deuterated using a ratio determination of the analogous MS transitions unique to the deuterated/non-deuterated compounds4. As a control, a second deuterated analogue was also synthesised4 with deuterium purposely incorporated at a site significantly less metabolised than the first site5, which our newly developed method was also able to confirm. We expect this simple and rapid method could be applied to deuterated and non-deuterated analogues of other biologically important molecules to determine the suitability of the chosen site of deuteration. For radiotracers, there is no requirement to radiolabel until studies progress to in vivo PET imaging.en_AU
dc.identifier.citationMurphy, R., Wyatt, N., Fraser, B., Yepuri, N., Holden, P., Wotherspoon, A. & Darwish, T. (2019). To D or not to D – an in vitro/mass spectrometry screening method to confirm improved metabolic stability in deuterium-labelled radiotracers. Paper presented at the ANSTO Young Researchers' Conference, Lucas Heights, NSW, Australia, 3 September 2019. Retrieved from: https://events01.synchrotron.org.au/event/98/book-of-abstracts.pdfen_AU
dc.identifier.conferencenameANSTO Young Researchers' Conferenceen_AU
dc.identifier.conferenceplaceLucas Heights, NSWen_AU
dc.identifier.conferencestartdate3 September 2019en_AU
dc.identifier.urihttps://events01.synchrotron.org.au/event/98/book-of-abstracts.pdfen_AU
dc.identifier.urihttps://apo.ansto.gov.au/dspace/handle/10238/11789en_AU
dc.language.isoenen_AU
dc.publisherAustralian Nuclear Science and Technology Organisationen_AU
dc.subjectSpectroscopyen_AU
dc.subjectMetabolismen_AU
dc.subjectDeuteriumen_AU
dc.subjectDeuterationen_AU
dc.subjectLabelled compoundsen_AU
dc.subjectTracer techniquesen_AU
dc.subjectIsotopesen_AU
dc.titleTo D or not to D – an in vitro/mass spectrometry screening method to confirm improved metabolic stability in deuterium-labelled radiotracersen_AU
dc.typeConference Abstracten_AU
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
book-of-abstracts ANSTO Young 2019.pdf
Size:
159.79 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.63 KB
Format:
Item-specific license agreed upon to submission
Description: